Anna Marinelli Andreoli

Pharmacokinetics and Pharmacodynamics of NPH Insulin in Type 1 Diabetes: The Importance of Appropriate Resuspension Before Subcutaneous Injection

Paola Lucidi, Francesca Porcellati, Anna Marinelli Andreoli et al. · Diabetes Care · 2015 · 73 citations

Medicine, Pharmacokinetics, Pharmacology +14

Pharmacokinetics and Pharmacodynamics of the Long-Acting Insulin Analog Glargine After 1 Week of Use Compared With Its First Administration in Subjects With Type 1 Diabetes

Francesca Porcellati, Paolo Rossetti, N Ricci et al. · Diabetes Care · 2007 · 64 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Pharmacokinetics and Pharmacodynamics of Therapeutic Doses of Basal Insulins NPH, Glargine, and Detemir After 1 Week of Daily Administration at Bedtime in Type 2 Diabetic Subjects

Paola Lucidi, Francesca Porcellati, Paolo Rossetti et al. · Diabetes Care · 2011 · 51 citations · Full text

Medicine, Endocrinology, Pharmacology +16

Pharmacokinetics and Pharmacodynamics of Insulin Glargine Given in the Evening as Compared With in the Morning in Type 2 Diabetes

Francesca Porcellati, Paola Lucidi, Patrizia Cioli et al. · Diabetes Care · 2014 · 51 citations

Medicine, Pharmacokinetics, Pharmacology +17

Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes

Paola Lucidi, Francesca Porcellati, Paolo Rossetti et al. · Diabetes Care · 2012 · 47 citations · Full text

Medicine, Endocrinology, Pharmacology +10